+91-22-48913909
ਫਿੰਕੈਸ਼ »ਮਿਉਚੁਅਲ ਫੰਡ »2018 ਲਈ ਵਧੀਆ ਪ੍ਰਦਰਸ਼ਨ ਕਰਨ ਵਾਲੇ ਸੈਕਟਰ ਫੰਡ
Table of Contents
- ਪ੍ਰਦਰਸ਼ਨ ਦੇ ਅਧਾਰ ਤੇ 2019 ਲਈ ਚੋਟੀ ਦੇ 10 ਪ੍ਰਦਰਸ਼ਨ ਕਰਨ ਵਾਲੇ ਸੈਕਟਰ ਮਿutਚੁਅਲ ਫੰਡ
- 2019 ਲਈ ਸਰਬੋਤਮ ਪ੍ਰਦਰਸ਼ਨ ਕਰਨ ਵਾਲੇ ਸੈਕਟਰ ਫੰਡ
Top 10 Equity - Sectoral Funds
2019 ਲਈ ਸਰਬੋਤਮ 10 ਪ੍ਰਦਰਸ਼ਨ ਕਰਨ ਵਾਲੇ ਸੈਕਟਰ ਫੰਡ
ਸੈਕਟਰਮਿਉਚੁਅਲ ਫੰਡ ਉਸ ਯੋਜਨਾ ਦਾ ਹਵਾਲਾ ਲਓ ਜੋ ਕਿਸੇ ਵਿਸ਼ੇਸ਼ ਖੇਤਰ ਨਾਲ ਸਬੰਧਤ ਕੰਪਨੀਆਂ ਦੇ ਇਕੁਇਟੀ ਸ਼ੇਅਰਾਂ ਵਿੱਚ ਆਪਣੇ ਫੰਡ ਦੀ ਰਕਮ ਦਾ ਇੱਕ ਪ੍ਰਮੁੱਖ ਹਿੱਸੇਦਾਰੀ ਨਿਵੇਸ਼ ਕਰਦੀ ਹੈ. ਇਹ ਯੋਜਨਾਵਾਂ ਉਹਨਾਂ ਵਿਅਕਤੀਆਂ ਦੁਆਰਾ ਭਾਲੀਆਂ ਜਾਂਦੀਆਂ ਹਨ ਜਿਨ੍ਹਾਂ ਦੀ ਭਾਲ ਕੀਤੀ ਜਾਂਦੀ ਹੈਉੱਚ ਰਿਟਰਨ ਦੇ ਨਾਲ ਨਾਲ ਆਪਣੇ ਨਿਵੇਸ਼ 'ਤੇਉੱਚ ਜੋਖਮ ਭੁੱਖ. ਕੁਝ ਖੇਤਰ ਜਿਨ੍ਹਾਂ ਵਿੱਚ ਮਿਉਚੁਅਲ ਫੰਡ ਆਮ ਤੌਰ ਤੇ ਉਨ੍ਹਾਂ ਦੀਆਂ ਯੋਜਨਾਵਾਂ ਦੀ ਪੇਸ਼ਕਸ਼ ਕਰਦੇ ਹਨ ਉਹਨਾਂ ਵਿੱਚ ਬੁਨਿਆਦੀ ,ਾਂਚਾ, ਫਾਰਮਾਸਿicalਟੀਕਲ, ਬੈਂਕਿੰਗ ਅਤੇ ਵਿੱਤੀ ਸੇਵਾਵਾਂ ਅਤੇ ਕੁਦਰਤੀ ਸਰੋਤ ਅਤੇ ਨਵੀਂ includeਰਜਾ ਸ਼ਾਮਲ ਹਨ. ਸਾਲ 2019 ਲਈ ਸੈਕਟਰਲ ਫੰਡਾਂ ਦੀ ਕਾਰਗੁਜ਼ਾਰੀ ਕਾਫ਼ੀ ਵਧੀਆ ਰਹੀ. ਆਰਥਿਕਤਾ ਵਿੱਚ ਹੋਏ ਵਿਕਾਸ ਨਾਲ, ਬਹੁਤ ਸਾਰੇ ਸੈਕਟਰਲ ਫੰਡਾਂ ਨੇ ਆਪਣੇ ਨਿਵੇਸ਼ਾਂ ਤੇ ਸਕਾਰਾਤਮਕ ਵਾਪਸੀ ਕੀਤੀ ਹੈ. ਇਸ ਲਈ, ਆਓ ਅਸੀਂ ਉਨ੍ਹਾਂ ਦੇ ਪ੍ਰਦਰਸ਼ਨ (ਰਿਟਰਨ) ਦੇ ਅਧਾਰ 'ਤੇ ਸਾਲ 2019 ਲਈ ਕੁਝ ਚੋਟੀ ਦੇ ਅਤੇ ਸਭ ਤੋਂ ਵਧੀਆ 10 ਪ੍ਰਦਰਸ਼ਨਕਾਰੀ ਖੇਤਰ ਦੇ ਮਿualਚੁਅਲ ਫੰਡਾਂ' ਤੇ ਧਿਆਨ ਦੇਈਏ.
Talk to our investment specialist
ਪ੍ਰਦਰਸ਼ਨ ਦੇ ਅਧਾਰ ਤੇ 2019 ਲਈ ਚੋਟੀ ਦੇ 10 ਪ੍ਰਦਰਸ਼ਨ ਕਰਨ ਵਾਲੇ ਸੈਕਟਰ ਮਿutਚੁਅਲ ਫੰਡ
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) LIC MF Infrastructure Fund Growth ₹43.6146
↑ 0.28 ₹763 47.8 44.4 7.9 46.6 -0.1 UTI Healthcare Fund Growth ₹265.67
↑ 1.21 ₹1,057 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹404.449
↓ -6.59 ₹3,313 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹28.4919
↑ 0.16 ₹1,104 40.4 36.6 -8 19.1 64.4 IDFC Infrastructure Fund Growth ₹46.073
↑ 0.20 ₹1,400 39.3 50.3 1.7 64.8 6.3 Franklin India Opportunities Fund Growth ₹227.72
↑ 2.21 ₹5,517 37.3 53.6 -1.9 29.7 27.3 L&T Business Cycles Fund Growth ₹39.0143
↑ 0.36 ₹855 36.3 31.3 5.3 34.5 9.3 Canara Robeco Infrastructure Growth ₹143.37
↑ 0.80 ₹726 35.3 41.2 9 56.1 9 Nippon India Pharma Fund Growth ₹477.044
↑ 3.00 ₹7,637 34 39.2 -9.9 23.9 66.4 Invesco India Infrastructure Fund Growth ₹56.94
↑ 0.31 ₹1,255 33.2 51.1 2.3 55.4 16.2 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 2 Apr 25
2019 ਲਈ ਸਰਬੋਤਮ ਪ੍ਰਦਰਸ਼ਨ ਕਰਨ ਵਾਲੇ ਸੈਕਟਰ ਫੰਡ
The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized. IDFC Infrastructure Fund is a Equity - Sectoral fund was launched on 8 Mar 11. It is a fund with High risk and has given a Below is the key information for IDFC Infrastructure Fund Returns up to 1 year are on The investment objective of Franklin India Opportunities Fund (FIOF) is to generate capital appreciation by capitalizing on the long-term growth opportunities in the Indian economy. Franklin India Opportunities Fund is a Equity - Sectoral fund was launched on 21 Feb 00. It is a fund with Moderately High risk and has given a Below is the key information for Franklin India Opportunities Fund Returns up to 1 year are on To seek to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related securities, including equity derivatives, in the Indian market with focus on riding business cycles through dynamic allocation between various sectors and stocks at different stages of business cycles in the economy L&T Business Cycles Fund is a Equity - Sectoral fund was launched on 20 Aug 14. It is a fund with Moderately High risk and has given a Below is the key information for L&T Business Cycles Fund Returns up to 1 year are on T o g e n e r a t e income/capital appreciation by investing in equities and equity related instruments of companies in the infrastructure sector. However, there can be no assurance that the investment objective of the scheme will be realized. Canara Robeco Infrastructure is a Equity - Sectoral fund was launched on 2 Dec 05. It is a fund with High risk and has given a Below is the key information for Canara Robeco Infrastructure Returns up to 1 year are on The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Nippon India Pharma Fund is a Equity - Sectoral fund was launched on 5 Jun 04. It is a fund with High risk and has given a Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of infrastructure companies. However, there can be no assurance that the investment objective of the Scheme will be achieved. Invesco India Infrastructure Fund is a Equity - Sectoral fund was launched on 21 Nov 07. It is a fund with High risk and has given a Below is the key information for Invesco India Infrastructure Fund Returns up to 1 year are on 1. LIC MF Infrastructure Fund
CAGR/Annualized return of 9% since its launch. Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (02 Apr 25) ₹43.6146 ↑ 0.28 (0.64 %) Net Assets (Cr) ₹763 on 28 Feb 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio 0.01 Information Ratio 0.28 Alpha Ratio 14.17 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹16,888 31 Mar 22 ₹22,193 31 Mar 23 ₹22,783 31 Mar 24 ₹36,820 31 Mar 25 ₹42,656 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 2 Apr 25 Duration Returns 1 Month 12.1% 3 Month -16.6% 6 Month -16.5% 1 Year 12.3% 3 Year 23.8% 5 Year 34.4% 10 Year 15 Year Since launch 9% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.53 Yr. Mahesh Bendre 1 Jul 24 0.75 Yr. Data below for LIC MF Infrastructure Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Industrials 53.11% Basic Materials 11.98% Consumer Cyclical 9.02% Utility 8.21% Financial Services 6.04% Real Estate 2.74% Technology 2.16% Communication Services 1.9% Energy 0.74% Health Care 0.65% Asset Allocation
Asset Class Value Cash 2.97% Equity 97.03% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP5% ₹37 Cr 456,240
↑ 9,011 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006555% ₹36 Cr 94,287 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 5004003% ₹25 Cr 724,927 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 5329553% ₹21 Cr 571,332 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER3% ₹20 Cr 332,049
↑ 536 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹20 Cr 490,363
↑ 54,480 Cummins India Ltd (Industrials)
Equity, Since 31 May 21 | 5004802% ₹18 Cr 66,848 Bharat Heavy Electricals Ltd (Industrials)
Equity, Since 31 May 24 | 5001032% ₹18 Cr 983,002 Bharat Forge Ltd (Consumer Cyclical)
Equity, Since 30 Sep 21 | 5004932% ₹16 Cr 160,178 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222752% ₹16 Cr 121,339 2. UTI Healthcare Fund
CAGR/Annualized return of 14.8% since its launch. Ranked 40 in Sectoral category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (02 Apr 25) ₹265.67 ↑ 1.21 (0.46 %) Net Assets (Cr) ₹1,057 on 28 Feb 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 0.28 Information Ratio -0.09 Alpha Ratio 1.36 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,396 31 Mar 22 ₹19,596 31 Mar 23 ₹17,899 31 Mar 24 ₹27,884 31 Mar 25 ₹33,479 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 2 Apr 25 Duration Returns 1 Month 7% 3 Month -10% 6 Month -8.7% 1 Year 17.8% 3 Year 19.1% 5 Year 27.4% 10 Year 15 Year Since launch 14.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 2.83 Yr. Data below for UTI Healthcare Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Health Care 98.22% Basic Materials 1.33% Asset Allocation
Asset Class Value Cash 0.45% Equity 99.55% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA11% ₹116 Cr 725,000 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000876% ₹65 Cr 464,949 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹48 Cr 432,608
↓ -37,626 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323314% ₹47 Cr 188,399
↑ 1,601 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹40 Cr 309,311 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND4% ₹37 Cr 240,012
↓ -465 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹37 Cr 74,000 Suven Pharmaceuticals Ltd (Healthcare)
Equity, Since 28 Feb 21 | SUVENPHAR3% ₹36 Cr 295,000
↑ 2,080 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹34 Cr 557,701 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP3% ₹34 Cr 56,271 3. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 15.4% since its launch. Ranked 34 in Sectoral category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (01 Apr 25) ₹404.449 ↓ -6.59 (-1.60 %) Net Assets (Cr) ₹3,313 on 28 Feb 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 0.35 Information Ratio 0.73 Alpha Ratio 2.13 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,177 31 Mar 22 ₹19,486 31 Mar 23 ₹19,107 31 Mar 24 ₹30,178 31 Mar 25 ₹36,162 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 2 Apr 25 Duration Returns 1 Month 5.6% 3 Month -7.7% 6 Month -3.9% 1 Year 16.9% 3 Year 22.3% 5 Year 29.2% 10 Year 15 Year Since launch 15.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 13.84 Yr. Data below for SBI Healthcare Opportunities Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Health Care 90.4% Basic Materials 6.89% Asset Allocation
Asset Class Value Cash 2.62% Equity 97.29% Debt 0.09% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA13% ₹446 Cr 2,800,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹215 Cr 2,200,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB6% ₹206 Cr 375,000
↓ -15,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹169 Cr 1,200,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY5% ₹166 Cr 300,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002575% ₹160 Cr 840,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND4% ₹128 Cr 560,000 Aether Industries Ltd (Basic Materials)
Equity, Since 31 May 22 | 5435344% ₹120 Cr 1,400,000 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL3% ₹115 Cr 800,000 Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | POLYMED3% ₹110 Cr 540,000
↑ 40,000 4. TATA India Pharma & Healthcare Fund
CAGR/Annualized return of 12% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (02 Apr 25) ₹28.4919 ↑ 0.16 (0.58 %) Net Assets (Cr) ₹1,104 on 28 Feb 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 0.04 Information Ratio 0.42 Alpha Ratio 0.96 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹16,489 31 Mar 22 ₹19,237 31 Mar 23 ₹17,775 31 Mar 24 ₹28,060 31 Mar 25 ₹32,066 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 2 Apr 25 Duration Returns 1 Month 7.2% 3 Month -11% 6 Month -8.5% 1 Year 12.7% 3 Year 18.5% 5 Year 26.5% 10 Year 15 Year Since launch 12% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 4.06 Yr. Rajat Srivastava 16 Sep 24 0.54 Yr. Data below for TATA India Pharma & Healthcare Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Health Care 95.87% Basic Materials 2.19% Asset Allocation
Asset Class Value Cash 1.94% Equity 98.06% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA12% ₹128 Cr 804,300 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | DRREDDY7% ₹80 Cr 714,555 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA7% ₹78 Cr 741,000 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000876% ₹69 Cr 490,000 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002576% ₹69 Cr 360,240 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB5% ₹58 Cr 104,965 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328435% ₹52 Cr 855,100 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP4% ₹44 Cr 72,635
↑ 13,732 Zydus Lifesciences Ltd (Healthcare)
Equity, Since 31 Dec 22 | 5323214% ₹41 Cr 471,287 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM3% ₹37 Cr 906,991
↑ 250,000 5. IDFC Infrastructure Fund
CAGR/Annualized return of 11.5% since its launch. Ranked 1 in Sectoral category. Return for 2024 was 39.3% , 2023 was 50.3% and 2022 was 1.7% . IDFC Infrastructure Fund
Growth Launch Date 8 Mar 11 NAV (02 Apr 25) ₹46.073 ↑ 0.20 (0.43 %) Net Assets (Cr) ₹1,400 on 28 Feb 25 Category Equity - Sectoral AMC IDFC Asset Management Company Limited Rating ☆☆☆☆☆ Risk High Expense Ratio 2.33 Sharpe Ratio -0.3 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹20,153 31 Mar 22 ₹24,848 31 Mar 23 ₹27,324 31 Mar 24 ₹47,064 31 Mar 25 ₹50,038 Returns for IDFC Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 2 Apr 25 Duration Returns 1 Month 13% 3 Month -12.1% 6 Month -18.2% 1 Year 3.2% 3 Year 25.8% 5 Year 38.6% 10 Year 15 Year Since launch 11.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.3% 2023 50.3% 2022 1.7% 2021 64.8% 2020 6.3% 2019 -5.3% 2018 -25.9% 2017 58.7% 2016 10.7% 2015 -0.2% Fund Manager information for IDFC Infrastructure Fund
Name Since Tenure Vishal Biraia 24 Jan 24 1.1 Yr. Ritika Behera 7 Oct 23 1.4 Yr. Gaurav Satra 7 Jun 24 0.73 Yr. Data below for IDFC Infrastructure Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Industrials 54.7% Utility 13.22% Basic Materials 10.84% Communication Services 4.49% Energy 3.88% Consumer Cyclical 3.46% Financial Services 2.99% Technology 2.07% Health Care 1.9% Asset Allocation
Asset Class Value Cash 2.43% Equity 97.57% Top Securities Holdings / Portfolio
Name Holding Value Quantity Kirloskar Brothers Ltd (Industrials)
Equity, Since 31 Dec 17 | KIRLOSBROS5% ₹71 Cr 443,385 Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT4% ₹58 Cr 183,173
↑ 11,726 Reliance Industries Ltd (Energy)
Equity, Since 30 Jun 24 | RELIANCE4% ₹54 Cr 452,706 Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 19 | BHARTIARTL4% ₹52 Cr 330,018
↑ 40,855 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 14 | 5325384% ₹51 Cr 50,452
↑ 3,476 GPT Infraprojects Ltd (Industrials)
Equity, Since 30 Nov 17 | GPTINFRA3% ₹45 Cr 4,797,143 Adani Ports & Special Economic Zone Ltd (Industrials)
Equity, Since 31 Dec 23 | ADANIPORTS3% ₹39 Cr 365,137
↓ -69,842 PTC India Financial Services Ltd (Financial Services)
Equity, Since 31 Dec 23 | PFS3% ₹39 Cr 12,400,122 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Oct 19 | BEL3% ₹35 Cr 1,431,700 KEC International Ltd (Industrials)
Equity, Since 30 Jun 24 | 5327143% ₹35 Cr 512,915 6. Franklin India Opportunities Fund
CAGR/Annualized return of 13.3% since its launch. Ranked 47 in Sectoral category. Return for 2024 was 37.3% , 2023 was 53.6% and 2022 was -1.9% . Franklin India Opportunities Fund
Growth Launch Date 21 Feb 00 NAV (02 Apr 25) ₹227.72 ↑ 2.21 (0.98 %) Net Assets (Cr) ₹5,517 on 28 Feb 25 Category Equity - Sectoral AMC Franklin Templeton Asst Mgmt(IND)Pvt Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 2.12 Sharpe Ratio 0.12 Information Ratio 1.45 Alpha Ratio 8.88 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹18,903 31 Mar 22 ₹21,132 31 Mar 23 ₹23,026 31 Mar 24 ₹37,539 31 Mar 25 ₹43,201 Returns for Franklin India Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 2 Apr 25 Duration Returns 1 Month 7% 3 Month -10.8% 6 Month -11.9% 1 Year 12.7% 3 Year 26.4% 5 Year 34.9% 10 Year 15 Year Since launch 13.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 37.3% 2023 53.6% 2022 -1.9% 2021 29.7% 2020 27.3% 2019 5.4% 2018 -10.1% 2017 35.6% 2016 4.2% 2015 2.3% Fund Manager information for Franklin India Opportunities Fund
Name Since Tenure Kiran Sebastian 7 Feb 22 3.06 Yr. R. Janakiraman 1 Apr 13 11.92 Yr. Sandeep Manam 18 Oct 21 3.37 Yr. Data below for Franklin India Opportunities Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Consumer Cyclical 19.47% Financial Services 13.37% Health Care 11.56% Communication Services 9.09% Basic Materials 8.49% Technology 7.97% Industrials 6.9% Energy 4.32% Consumer Defensive 3.74% Real Estate 2.22% Utility 1.37% Asset Allocation
Asset Class Value Cash 8.98% Equity 91.02% Top Securities Holdings / Portfolio
Name Holding Value Quantity HDFC Bank Ltd (Financial Services)
Equity, Since 31 May 24 | HDFCBANK5% ₹301 Cr 1,735,296
↑ 676,365 Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE4% ₹238 Cr 1,987,098 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Jan 24 | BHARTIARTL4% ₹211 Cr 1,342,233 Mahindra & Mahindra Ltd (Consumer Cyclical)
Equity, Since 31 May 24 | M&M3% ₹165 Cr 637,966 Mphasis Ltd (Technology)
Equity, Since 30 Nov 24 | 5262993% ₹160 Cr 710,533 Lemon Tree Hotels Ltd (Consumer Cyclical)
Equity, Since 31 Aug 24 | LEMONTREE3% ₹156 Cr 12,833,401 Info Edge (India) Ltd (Communication Services)
Equity, Since 31 Jul 24 | NAUKRI3% ₹151 Cr 216,138 APL Apollo Tubes Ltd (Basic Materials)
Equity, Since 31 Oct 24 | APLAPOLLO3% ₹144 Cr 998,385 Zomato Ltd (Consumer Cyclical)
Equity, Since 31 Aug 23 | 5433203% ₹142 Cr 6,398,413 CE Info Systems Ltd (Technology)
Equity, Since 31 Mar 24 | 5434253% ₹139 Cr 835,883
↑ 76,164 7. L&T Business Cycles Fund
CAGR/Annualized return of 13.7% since its launch. Ranked 19 in Sectoral category. Return for 2024 was 36.3% , 2023 was 31.3% and 2022 was 5.3% . L&T Business Cycles Fund
Growth Launch Date 20 Aug 14 NAV (02 Apr 25) ₹39.0143 ↑ 0.36 (0.93 %) Net Assets (Cr) ₹855 on 28 Feb 25 Category Equity - Sectoral AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk Moderately High Expense Ratio 2.43 Sharpe Ratio -0.21 Information Ratio 0.54 Alpha Ratio 2.8 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-18 Months (1%),18 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,684 31 Mar 22 ₹21,100 31 Mar 23 ₹22,192 31 Mar 24 ₹31,871 31 Mar 25 ₹36,168 Returns for L&T Business Cycles Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 2 Apr 25 Duration Returns 1 Month 12.3% 3 Month -11.2% 6 Month -12.7% 1 Year 10.6% 3 Year 19.4% 5 Year 30.1% 10 Year 15 Year Since launch 13.7% Historical performance (Yearly) on absolute basis
Year Returns 2024 36.3% 2023 31.3% 2022 5.3% 2021 34.5% 2020 9.3% 2019 5.3% 2018 -17.5% 2017 45.6% 2016 3.2% 2015 3.5% Fund Manager information for L&T Business Cycles Fund
Name Since Tenure Venugopal Manghat 20 Aug 14 10.54 Yr. Gautam Bhupal 1 Jun 23 1.75 Yr. Sonal Gupta 1 Jun 23 1.75 Yr. Data below for L&T Business Cycles Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Financial Services 32.32% Industrials 26.49% Consumer Cyclical 15.62% Basic Materials 12.41% Energy 7.28% Technology 1.39% Real Estate 0.94% Asset Allocation
Asset Class Value Cash 2.29% Equity 97.71% Top Securities Holdings / Portfolio
Name Holding Value Quantity ICICI Bank Ltd (Financial Services)
Equity, Since 31 Aug 14 | ICICIBANK6% ₹51 Cr 425,000 Reliance Industries Ltd (Energy)
Equity, Since 31 Aug 18 | RELIANCE6% ₹48 Cr 401,700
↑ 36,300 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 31 Dec 22 | MCX6% ₹47 Cr 94,300 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Dec 16 | 5002515% ₹46 Cr 95,680 HDFC Bank Ltd (Financial Services)
Equity, Since 31 Aug 14 | HDFCBANK5% ₹43 Cr 246,800
↑ 53,500 Larsen & Toubro Ltd (Industrials)
Equity, Since 31 Aug 14 | LT3% ₹26 Cr 81,830 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Dec 22 | BEL3% ₹25 Cr 1,000,000 Blue Star Ltd (Industrials)
Equity, Since 31 Aug 14 | BLUESTARCO3% ₹23 Cr 119,800 Power Finance Corp Ltd (Financial Services)
Equity, Since 31 Jan 24 | 5328103% ₹22 Cr 603,200 PB Fintech Ltd (Financial Services)
Equity, Since 31 Dec 23 | 5433903% ₹22 Cr 149,200 8. Canara Robeco Infrastructure
CAGR/Annualized return of 14.8% since its launch. Return for 2024 was 35.3% , 2023 was 41.2% and 2022 was 9% . Canara Robeco Infrastructure
Growth Launch Date 2 Dec 05 NAV (02 Apr 25) ₹143.37 ↑ 0.80 (0.56 %) Net Assets (Cr) ₹726 on 28 Feb 25 Category Equity - Sectoral AMC Canara Robeco Asset Management Co. Ltd. Rating Risk High Expense Ratio 2.47 Sharpe Ratio 0.02 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,577 31 Mar 22 ₹22,500 31 Mar 23 ₹25,245 31 Mar 24 ₹38,923 31 Mar 25 ₹44,217 Returns for Canara Robeco Infrastructure
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 2 Apr 25 Duration Returns 1 Month 10.6% 3 Month -10.4% 6 Month -15.3% 1 Year 10.2% 3 Year 24.5% 5 Year 35.1% 10 Year 15 Year Since launch 14.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 35.3% 2023 41.2% 2022 9% 2021 56.1% 2020 9% 2019 2.3% 2018 -19.1% 2017 40.2% 2016 2.1% 2015 6.7% Fund Manager information for Canara Robeco Infrastructure
Name Since Tenure Vishal Mishra 26 Jun 21 3.68 Yr. Shridatta Bhandwaldar 29 Sep 18 6.42 Yr. Data below for Canara Robeco Infrastructure as on 28 Feb 25
Equity Sector Allocation
Sector Value Industrials 47.44% Utility 13.69% Basic Materials 9.57% Energy 8.57% Financial Services 6.82% Technology 3.25% Communication Services 2.95% Consumer Cyclical 2.95% Real Estate 1.63% Asset Allocation
Asset Class Value Cash 3.13% Equity 96.87% Top Securities Holdings / Portfolio
Name Holding Value Quantity Larsen & Toubro Ltd (Industrials)
Equity, Since 28 Feb 11 | LT7% ₹47 Cr 149,401
↑ 6,000 NTPC Ltd (Utilities)
Equity, Since 30 Nov 18 | 5325555% ₹35 Cr 1,131,666 InterGlobe Aviation Ltd (Industrials)
Equity, Since 31 Jan 23 | INDIGO4% ₹30 Cr 67,250 Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE4% ₹30 Cr 250,250
↑ 5,500 Tata Power Co Ltd (Utilities)
Equity, Since 30 Sep 24 | 5004004% ₹27 Cr 785,000 State Bank of India (Financial Services)
Equity, Since 31 Jul 24 | SBIN4% ₹25 Cr 370,000
↑ 50,000 Power Finance Corp Ltd (Financial Services)
Equity, Since 30 Nov 23 | 5328103% ₹24 Cr 660,000
↑ 50,000 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 31 Oct 09 | 5328983% ₹24 Cr 957,546 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Oct 23 | DIXON3% ₹24 Cr 16,950 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Jul 19 | BEL3% ₹23 Cr 919,000 9. Nippon India Pharma Fund
CAGR/Annualized return of 20.4% since its launch. Ranked 35 in Sectoral category. Return for 2024 was 34% , 2023 was 39.2% and 2022 was -9.9% . Nippon India Pharma Fund
Growth Launch Date 5 Jun 04 NAV (02 Apr 25) ₹477.044 ↑ 3.00 (0.63 %) Net Assets (Cr) ₹7,637 on 28 Feb 25 Category Equity - Sectoral AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk High Expense Ratio 1.88 Sharpe Ratio -0.03 Information Ratio -0.33 Alpha Ratio -3.9 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,447 31 Mar 22 ₹20,234 31 Mar 23 ₹18,871 31 Mar 24 ₹29,909 31 Mar 25 ₹33,564 Returns for Nippon India Pharma Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 2 Apr 25 Duration Returns 1 Month 5.6% 3 Month -10.1% 6 Month -8.7% 1 Year 10.2% 3 Year 18% 5 Year 27.6% 10 Year 15 Year Since launch 20.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 34% 2023 39.2% 2022 -9.9% 2021 23.9% 2020 66.4% 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% Fund Manager information for Nippon India Pharma Fund
Name Since Tenure Sailesh Raj Bhan 1 Apr 05 20.01 Yr. Kinjal Desai 25 May 18 6.86 Yr. Data below for Nippon India Pharma Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Health Care 98.89% Asset Allocation
Asset Class Value Cash 1.11% Equity 98.89% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA14% ₹1,045 Cr 6,556,349 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB9% ₹712 Cr 1,298,808
↓ -52,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | 5002578% ₹590 Cr 3,098,126
↓ -102,567 Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | 5000876% ₹450 Cr 3,200,000
↑ 100,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | DRREDDY5% ₹409 Cr 3,662,170 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Sep 20 | APOLLOHOSP5% ₹393 Cr 648,795 Abbott India Ltd (Healthcare)
Equity, Since 31 May 11 | ABBOTINDIA4% ₹292 Cr 95,985
↑ 9,595 Vijaya Diagnostic Centre Ltd (Healthcare)
Equity, Since 30 Sep 21 | 5433503% ₹260 Cr 2,843,231 Medplus Health Services Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5434273% ₹259 Cr 3,627,277
↑ 62,597 GlaxoSmithKline Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | GLAXO3% ₹250 Cr 1,011,921
↑ 179,134 10. Invesco India Infrastructure Fund
CAGR/Annualized return of 10.5% since its launch. Ranked 24 in Sectoral category. Return for 2024 was 33.2% , 2023 was 51.1% and 2022 was 2.3% . Invesco India Infrastructure Fund
Growth Launch Date 21 Nov 07 NAV (02 Apr 25) ₹56.94 ↑ 0.31 (0.55 %) Net Assets (Cr) ₹1,255 on 28 Feb 25 Category Equity - Sectoral AMC Invesco Asset Management (India) Private Ltd Rating ☆☆☆ Risk High Expense Ratio 2.34 Sharpe Ratio -0.37 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,093 31 Mar 22 ₹22,504 31 Mar 23 ₹23,767 31 Mar 24 ₹40,140 31 Mar 25 ₹41,997 Returns for Invesco India Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 2 Apr 25 Duration Returns 1 Month 12.6% 3 Month -13.5% 6 Month -17.1% 1 Year 1.6% 3 Year 22.5% 5 Year 33.6% 10 Year 15 Year Since launch 10.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 33.2% 2023 51.1% 2022 2.3% 2021 55.4% 2020 16.2% 2019 6.1% 2018 -15.8% 2017 48.1% 2016 0.8% 2015 -2.6% Fund Manager information for Invesco India Infrastructure Fund
Name Since Tenure Amit Nigam 3 Sep 20 4.49 Yr. Sagar Gandhi 1 Mar 25 0 Yr. Data below for Invesco India Infrastructure Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Industrials 53.28% Consumer Cyclical 8.64% Basic Materials 8.14% Utility 6.86% Communication Services 6.52% Health Care 3.7% Technology 3.49% Energy 2.44% Financial Services 1.89% Real Estate 1.59% Asset Allocation
Asset Class Value Cash 3.44% Equity 96.56% Top Securities Holdings / Portfolio
Name Holding Value Quantity Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Aug 21 | BHARTIARTL7% ₹82 Cr 521,351
↑ 143,771 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 30 Apr 22 | 5328984% ₹53 Cr 2,097,430 Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT4% ₹47 Cr 149,372
↓ -68,891 Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Sep 22 | DIXON3% ₹44 Cr 31,418 Supreme Industries Ltd (Industrials)
Equity, Since 30 Apr 24 | 5099303% ₹40 Cr 119,835
↑ 48,728 ZF Commercial Vehicle Control Systems India Ltd (Consumer Cyclical)
Equity, Since 30 Jun 23 | ZFCVINDIA3% ₹40 Cr 36,236 PTC Industries Ltd (Industrials)
Equity, Since 30 Sep 24 | 5390063% ₹39 Cr 38,640
↑ 5,064 Indian Railway Catering And Tourism Corp Ltd (Industrials)
Equity, Since 30 Apr 24 | IRCTC3% ₹38 Cr 565,828
↑ 73,233 Hitachi Energy India Ltd Ordinary Shares (Industrials)
Equity, Since 30 Nov 24 | POWERINDIA3% ₹38 Cr 33,412 Ramco Cements Ltd (Basic Materials)
Equity, Since 31 Jul 23 | RAMCOCEM3% ₹37 Cr 448,912
↑ 58,458
ਇੱਥੇ ਪ੍ਰਦਾਨ ਕੀਤੀ ਜਾਣਕਾਰੀ ਨੂੰ ਸਹੀ ਬਣਾਉਣ ਲਈ ਸਾਰੇ ਯਤਨ ਕੀਤੇ ਗਏ ਹਨ. ਹਾਲਾਂਕਿ, ਅੰਕੜਿਆਂ ਦੀ ਸ਼ੁੱਧਤਾ ਦੇ ਸੰਬੰਧ ਵਿੱਚ ਕੋਈ ਗਰੰਟੀ ਨਹੀਂ ਦਿੱਤੀ ਜਾਂਦੀ. ਕਿਰਪਾ ਕਰਕੇ ਕੋਈ ਵੀ ਨਿਵੇਸ਼ ਕਰਨ ਤੋਂ ਪਹਿਲਾਂ ਯੋਜਨਾ ਜਾਣਕਾਰੀ ਦਸਤਾਵੇਜ਼ ਨਾਲ ਜਾਂਚ ਕਰੋ.
You Might Also Like
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved